{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T06:39:41Z","timestamp":1792823981238,"version":"4.5.0"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100030692","name":"Intramural Research Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100030692","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.canlet.2026.218887","type":"journal-article","created":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T23:48:22Z","timestamp":1791503302000},"page":"218887","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Genome-wide CRISPR screen identifies PKMYT1 inhibition as a synthetic lethal vulnerability in IDH1-mutant glioma"],"prefix":"10.1016","volume":"661","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4617-938X","authenticated-orcid":false,"given":"Fengchao","family":"Lang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiqing","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karambir","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meili","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abiola A.","family":"Ayanlaja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md Shahadat","family":"Hossain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirit I.","family":"Aladjem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6433-0867","authenticated-orcid":false,"given":"Chunzhang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.canlet.2026.218887_bib1","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/s41571-021-00521-0","article-title":"The implications of IDH mutations for cancer development and therapy","volume":"18","author":"Pirozzi","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.canlet.2026.218887_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines8090294","article-title":"Isocitrate dehydrogenase mutations in glioma: genetics, biochemistry, and clinical indications","volume":"8","author":"Liu","year":"2020","journal-title":"Biomedicines"},{"issue":"7300","key":"10.1016\/j.canlet.2026.218887_bib3","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/nature09132","article-title":"Cancer-associated IDH1 mutations produce 2-hydroxyglutarate","volume":"465","author":"Dang","year":"2010","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.canlet.2026.218887_bib4","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.ccr.2010.03.017","article-title":"Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma","volume":"17","author":"Noushmehr","year":"2010","journal-title":"Cancer Cell"},{"issue":"7390","key":"10.1016\/j.canlet.2026.218887_bib5","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/nature10860","article-title":"IDH mutation impairs histone demethylation and results in a block to cell differentiation","volume":"483","author":"Lu","year":"2012","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.canlet.2026.218887_bib6","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1038\/s41467-025-56781-2","article-title":"D-2-hydroxyglutarate impairs DNA repair through epigenetic reprogramming","volume":"16","author":"Lang","year":"2025","journal-title":"Nat. Commun."},{"issue":"7813","key":"10.1016\/j.canlet.2026.218887_bib7","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/s41586-020-2363-0","article-title":"Oncometabolites suppress DNA repair by disrupting local chromatin signalling","volume":"582","author":"Sulkowski","year":"2020","journal-title":"Nature"},{"issue":"6796","key":"10.1016\/j.canlet.2026.218887_bib8","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/35020506","article-title":"Regulation of chromatin structure by site-specific histone H3 methyltransferases","volume":"406","author":"Rea","year":"2000","journal-title":"Nature"},{"issue":"14","key":"10.1016\/j.canlet.2026.218887_bib9","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/S0960-9822(03)00432-9","article-title":"Suv39h-mediated histone H3 lysine 9 methylation directs DNA methylation to major satellite repeats at pericentric heterochromatin","volume":"13","author":"Lehnertz","year":"2003","journal-title":"Curr. Biol."},{"issue":"8","key":"10.1016\/j.canlet.2026.218887_bib10","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a010207","article-title":"Chromatin and DNA replication","volume":"5","author":"MacAlpine","year":"2013","journal-title":"Cold Spring Harbor Perspect. Biol."},{"issue":"5","key":"10.1016\/j.canlet.2026.218887_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1006007","article-title":"Slow replication fork velocity of homologous recombination-defective cells results from endogenous oxidative stress","volume":"12","author":"Wilhelm","year":"2016","journal-title":"PLoS Genet."},{"issue":"1","key":"10.1016\/j.canlet.2026.218887_bib12","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41573-022-00558-5","article-title":"Targeting replication stress in cancer therapy","volume":"22","author":"da Costa","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"issue":"15","key":"10.1016\/j.canlet.2026.218887_bib13","doi-asserted-by":"crossref","first-page":"7936","DOI":"10.1093\/nar\/gkad543","article-title":"Alteration of replication protein A binding mode on single-stranded DNA by NSMF potentiates RPA phosphorylation by ATR kinase","volume":"51","author":"Kang","year":"2023","journal-title":"Nucleic Acids Res."},{"issue":"18","key":"10.1016\/j.canlet.2026.218887_bib14","doi-asserted-by":"crossref","first-page":"3841","DOI":"10.1158\/0008-5472.CAN-20-1744","article-title":"BRG1 loss predisposes lung cancers to replicative stress and ATR dependency","volume":"80","author":"Gupta","year":"2020","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.canlet.2026.218887_bib15","doi-asserted-by":"crossref","DOI":"10.1093\/narcan\/zcaa005","article-title":"SMARCA4 deficiency-associated heterochromatin induces intrinsic DNA replication stress and susceptibility to ATR inhibition in lung adenocarcinoma","volume":"2","author":"Kurashima","year":"2020","journal-title":"NAR Cancer"},{"issue":"1","key":"10.1016\/j.canlet.2026.218887_bib16","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41392-024-02080-z","article-title":"Cyclin-dependent protein kinases and cell cycle regulation in biology and disease","volume":"10","author":"Pellarin","year":"2025","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"23","key":"10.1016\/j.canlet.2026.218887_bib17","doi-asserted-by":"crossref","first-page":"5971","DOI":"10.1158\/0008-5472.CAN-19-1961","article-title":"Upregulation of Myt1 promotes acquired resistance of cancer cells to Wee1 inhibition","volume":"79","author":"Lewis","year":"2019","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.canlet.2026.218887_bib18","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1016\/j.celrep.2015.11.021","article-title":"Genome-wide CRISPR-Cas9 screens reveal loss of redundancy between PKMYT1 and WEE1 in glioblastoma stem-like cells","volume":"13","author":"Toledo","year":"2015","journal-title":"Cell Rep."},{"issue":"7907","key":"10.1016\/j.canlet.2026.218887_bib19","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-022-04638-9","article-title":"Amplification is synthetic lethal with PKMYT1 kinase inhibition","volume":"604","author":"Gallo","year":"2022","journal-title":"Nature"},{"issue":"830","key":"10.1016\/j.canlet.2026.218887_bib20","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adx6797","article-title":"Rb1 deficiency induces synthetic lethality with ATR and PKMYT1 coinhibition in breast cancer cell lines and patient-derived xenografts","volume":"17","author":"Jiang","year":"2025","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.canlet.2026.218887_bib21","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1038\/s41467-025-58183-w","article-title":"Targeting CCNE1 amplified ovarian and endometrial cancers by combined inhibition of PKMYT1 and ATR","volume":"16","author":"Xu","year":"2025","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.canlet.2026.218887_bib22","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1038\/s44321-024-00060-y","article-title":"Genome-wide CRISPR screens identify PKMYT1 as a therapeutic target in pancreatic ductal adenocarcinoma","volume":"16","author":"Wang","year":"2024","journal-title":"EMBO Mol. Med."},{"issue":"13","key":"10.1016\/j.canlet.2026.218887_bib23","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1016\/j.molcel.2023.05.026","article-title":"Oncogenic IDH mutations increase heterochromatin-related replication stress without impacting homologous recombination","volume":"83","author":"Schvartzman","year":"2023","journal-title":"Mol. Cell"},{"issue":"11","key":"10.1016\/j.canlet.2026.218887_bib24","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkaf512","article-title":"R-2-hydroxyglutarate-mediated inhibition of KDM4A compromises telomere integrity","volume":"53","author":"Couteau","year":"2025","journal-title":"Nucleic Acids Res."},{"issue":"7","key":"10.1016\/j.canlet.2026.218887_bib25","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.1093\/nar\/gkab195","article-title":"RPA2 winged-helix domain facilitates UNG-Mediated removal of uracil from ssDNA; implications for repair of mutagenic uracil at the replication fork","volume":"49","author":"Kavli","year":"2021","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.canlet.2026.218887_bib26","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/cr.2014.147","article-title":"RPA-Coated single-stranded DNA as a platform for post-translational modifications in the DNA damage response","volume":"25","author":"Mar\u00e9chal","year":"2015","journal-title":"Cell Res."},{"issue":"1","key":"10.1016\/j.canlet.2026.218887_bib27","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/ncb2897","article-title":"Causes and consequences of replication stress","volume":"16","author":"Zeman","year":"2014","journal-title":"Nat. Cell Biol."},{"issue":"9","key":"10.1016\/j.canlet.2026.218887_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/cells10092345","article-title":"D-2-Hydroxyglutarate in glioma biology","volume":"10","author":"Chou","year":"2021","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.canlet.2026.218887_bib29","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00412-015-0545-6","article-title":"Linking replication stress with heterochromatin formation","volume":"125","author":"Nikolov","year":"2016","journal-title":"Chromosoma"},{"issue":"18","key":"10.1016\/j.canlet.2026.218887_bib30","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1016\/j.molcel.2025.08.025","article-title":"Requirements for establishment and epigenetic stability of Mammalian heterochromatin","volume":"85","author":"Tatarakis","year":"2025","journal-title":"Mol. Cell"},{"key":"10.1016\/j.canlet.2026.218887_bib31","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.17903","article-title":"A histone H3K9M mutation traps histone methyltransferase Clr4 to prevent heterochromatin spreading","volume":"5","author":"Shan","year":"2016","journal-title":"eLife"},{"issue":"4","key":"10.1016\/j.canlet.2026.218887_bib32","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.molcel.2020.09.028","article-title":"H3 K27M and EZHIP impede H3K27-Methylation spreading by inhibiting allosterically stimulated PRC2","volume":"80","author":"Jain","year":"2020","journal-title":"Mol. Cell"},{"key":"10.1016\/j.canlet.2026.218887_bib33","article-title":"Targeting WEE1 enhances the antitumor effect of KRAS-Mutated non-small cell lung cancer harboring TP53 mutation","volume":"116","author":"Fukuda","year":"2025","journal-title":"Cancer Sci."},{"issue":"14","key":"10.1016\/j.canlet.2026.218887_bib34","doi-asserted-by":"crossref","DOI":"10.1172\/JCI181062","article-title":"BRCAness, DNA gaps, and gain and loss of PARP inhibitor-induced synthetic lethality","volume":"134","author":"Li","year":"2024","journal-title":"J. Clin. Investig."},{"issue":"4","key":"10.1016\/j.canlet.2026.218887_bib35","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/s41416-021-01405-x","article-title":"Phase 1 study of the ATR inhibitor berzosertib (formerly M6620, VX-970) combined with gemcitabine +\/- cisplatin in patients with advanced solid tumours","volume":"125","author":"Middleton","year":"2021","journal-title":"Br. J. Cancer"},{"issue":"6","key":"10.1016\/j.canlet.2026.218887_bib36","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1158\/0008-5472.CAN-21-2997","article-title":"ATR inhibitor AZD6738 (ceralasertib) exerts antitumor activity as a monotherapy and in combination with chemotherapy and the PARP inhibitor olaparib","volume":"82","author":"Wilson","year":"2022","journal-title":"Cancer Res."},{"issue":"10","key":"10.1016\/j.canlet.2026.218887_bib37","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1158\/1078-0432.CCR-23-2409","article-title":"First-in-Human study of the ataxia telangiectasia and Rad3-Related (ATR) inhibitor tuvusertib (M1774) as monotherapy in patients with solid tumors","volume":"30","author":"Yap","year":"2024","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.canlet.2026.218887_bib38","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1021\/acs.jmedchem.3c01917","article-title":"Discovery of the potent and selective ATR inhibitor camonsertib (RP-3500)","volume":"67","author":"Black","year":"2024","journal-title":"J. Med. Chem."},{"issue":"14","key":"10.1016\/j.canlet.2026.218887_bib39","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.1158\/1078-0432.CCR-17-3347","article-title":"Evaluation of prexasertib, a checkpoint kinase 1 inhibitor, in a phase Ib study of patients with squamous cell carcinoma","volume":"24","author":"Hong","year":"2018","journal-title":"Clin. Cancer Res."},{"issue":"16","key":"10.1016\/j.canlet.2026.218887_bib40","doi-asserted-by":"crossref","first-page":"4412","DOI":"10.1158\/1078-0432.CCR-12-3748","article-title":"Sensitization of pancreatic cancer to chemoradiation by the Chk1 inhibitor MK8776","volume":"19","author":"Engelke","year":"2013","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.canlet.2026.218887_bib41","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41416-023-02279-x","article-title":"A phase 1\/2 trial of SRA737 (A Chk1 inhibitor) administered orally in patients with advanced cancer","volume":"129","author":"Kristeleit","year":"2023","journal-title":"Br. J. Cancer"},{"issue":"14","key":"10.1016\/j.canlet.2026.218887_bib42","doi-asserted-by":"crossref","first-page":"3834","DOI":"10.1158\/1078-0432.CCR-21-0329","article-title":"Safety, antitumor activity, and biomarker analysis in a phase I trial of the once-daily Wee1 inhibitor adavosertib (AZD1775) in patients with advanced solid tumors","volume":"27","author":"Takebe","year":"2021","journal-title":"Clin. Cancer Res."},{"issue":"17","key":"10.1016\/j.canlet.2026.218887_bib43","doi-asserted-by":"crossref","first-page":"13004","DOI":"10.1021\/acs.jmedchem.1c01121","article-title":"Discovery of ZN-c3, a highly potent and selective Wee1 inhibitor undergoing evaluation in clinical trials for the treatment of cancer","volume":"64","author":"Huang","year":"2021","journal-title":"J. Med. Chem."},{"issue":"22","key":"10.1016\/j.canlet.2026.218887_bib44","doi-asserted-by":"crossref","first-page":"3864","DOI":"10.1158\/0008-5472.CAN-23-4130","article-title":"Low-molecular weight cyclin E confers a vulnerability to PKMYT1 inhibition in triple-negative breast cancer","volume":"84","author":"Li","year":"2024","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.canlet.2026.218887_bib45","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1093\/neuonc\/noad252","article-title":"Abrogation of the G2\/M checkpoint as a chemosensitization approach for alkylating agents","volume":"26","author":"Lang","year":"2024","journal-title":"Neuro Oncol."},{"issue":"1","key":"10.1016\/j.canlet.2026.218887_bib46","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-025-02250-7","article-title":"PKMYT1 kinase ameliorates cisplatin sensitivity in osteosarcoma","volume":"10","author":"Liu","year":"2025","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"7","key":"10.1016\/j.canlet.2026.218887_bib47","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1158\/0008-5472.CAN-16-2773","article-title":"Chemosensitivity of IDH1-Mutated gliomas due to an impairment in PARP1-Mediated DNA repair","volume":"77","author":"Lu","year":"2017","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.canlet.2026.218887_bib48","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41467-019-08530-5","article-title":"NADP(+) is an endogenous PARP inhibitor in DNA damage response and tumor suppression","volume":"10","author":"Bian","year":"2019","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.canlet.2026.218887_bib49","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1158\/2159-8290.CD-20-0226","article-title":"Poly(ADP-ribose) glycohydrolase inhibition sequesters NAD(+) to potentiate the metabolic lethality of alkylating chemotherapy in IDH-mutant tumor cells","volume":"10","author":"Nagashima","year":"2020","journal-title":"Cancer Discov."},{"issue":"15","key":"10.1016\/j.canlet.2026.218887_bib50","doi-asserted-by":"crossref","first-page":"4102","DOI":"10.1158\/0008-5472.CAN-16-2263","article-title":"The alkylating chemotherapeutic temozolomide induces metabolic stress in IDH1-Mutant cancers and potentiates NAD(+) depletion-mediated cytotoxicity","volume":"77","author":"Tateishi","year":"2017","journal-title":"Cancer Res."},{"issue":"375","key":"10.1016\/j.canlet.2026.218887_bib51","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aal2463","article-title":"2-Hydroxyglutarate produced by neomorphic IDH mutations suppresses homologous recombination and induces PARP inhibitor sensitivity","volume":"9","author":"Sulkowski","year":"2017","journal-title":"Sci. Transl. Med."},{"issue":"5","key":"10.1016\/j.canlet.2026.218887_bib52","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/embor.2011.43","article-title":"The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases","volume":"12","author":"Chowdhury","year":"2011","journal-title":"EMBO Rep."},{"issue":"1","key":"10.1016\/j.canlet.2026.218887_bib53","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ccr.2010.12.014","article-title":"Oncometabolite 2-Hydroxyglutarate is a competitive inhibitor of \u03b1-Ketoglutarate-Dependent dioxygenases","volume":"19","author":"Xu","year":"2011","journal-title":"Cancer Cell"},{"issue":"7813","key":"10.1016\/j.canlet.2026.218887_bib54","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/d41586-020-01569-1","article-title":"Tumour metabolites hinder DNA repair","volume":"582","author":"Chen","year":"2020","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.canlet.2026.218887_bib55","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/j.molcel.2023.04.020","article-title":"The molecular basis of heterochromatin assembly and epigenetic inheritance","volume":"83","author":"Grewal","year":"2023","journal-title":"Mol. Cell"},{"issue":"10","key":"10.1016\/j.canlet.2026.218887_bib56","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1016\/j.molcel.2021.02.038","article-title":"Targeting KDM4A epigenetically activates tumor-cell-intrinsic immunity by inducing DNA replication stress","volume":"81","author":"Zhang","year":"2021","journal-title":"Mol. Cell"},{"key":"10.1016\/j.canlet.2026.218887_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2022.100790","article-title":"Phenotypic and molecular states of IDH1 mutation-induced CD24-positive glioma stem-like cells","volume":"28","author":"Haddock","year":"2022","journal-title":"Neoplasia"},{"issue":"12","key":"10.1016\/j.canlet.2026.218887_bib58","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1158\/1541-7786.MCR-19-0995","article-title":"Adenosine A2A receptor activation enhances blood-tumor barrier permeability in a rodent glioma model","volume":"19","author":"Vezina","year":"2021","journal-title":"Mol. Cancer Res."},{"issue":"2","key":"10.1016\/j.canlet.2026.218887_bib59","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1083\/jcb.201604054","article-title":"A USP28-53BP1-p53-p21 signaling axis arrests growth after centrosome loss or prolonged mitosis","volume":"214","author":"Lambrus","year":"2016","journal-title":"J. Cell Biol."},{"issue":"12","key":"10.1016\/j.canlet.2026.218887_bib60","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0051407","article-title":"Histone demethylase jumonji D3 (JMJD3) as a tumor suppressor by regulating p53 protein nuclear stabilization","volume":"7","author":"Ene","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.canlet.2026.218887_bib61","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0118781","article-title":"Metabolic reprogramming in mutant IDH1 glioma cells","volume":"10","author":"Izquierdo-Garcia","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.canlet.2026.218887_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2019.02.041","article-title":"Essential gene profiles for human pluripotent stem cells identify uncharacterized genes and substrate dependencies","volume":"27","author":"Mair","year":"2019","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.canlet.2026.218887_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2021.100321","article-title":"Genome-scale chemogenomic CRISPR screens in human cells using the TKOv3 library","volume":"2","author":"Olivieri","year":"2021","journal-title":"STAR Protoc."},{"issue":"29","key":"10.1016\/j.canlet.2026.218887_bib64","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2502285122","article-title":"mtKO: a dedicated guide RNA library for mitochondria research","volume":"122","author":"Kaur","year":"2025","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.canlet.2026.218887_bib65","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.cell.2020.05.040","article-title":"A genetic map of the response to DNA damage in human cells","volume":"182","author":"Olivieri","year":"2020","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.canlet.2026.218887_bib66","doi-asserted-by":"crossref","DOI":"10.1186\/s13073-020-00809-3","article-title":"Improved analysis of CRISPR fitness screens and reduced off-target effects with the BAGEL2 gene essentiality classifier","volume":"13","author":"Kim","year":"2021","journal-title":"Genome Med."},{"issue":"9","key":"10.1016\/j.canlet.2026.218887_bib67","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1038\/s41588-018-0208-7","article-title":"Analysis and visualization of linked molecular and clinical cancer data by using oncoscape","volume":"50","author":"McFerrin","year":"2018","journal-title":"Nat. Genet."},{"issue":"2","key":"10.1016\/j.canlet.2026.218887_bib68","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/neuonc\/noaf251","article-title":"Integrated transcriptomic landscape of medulloblastoma and ependymoma reveals novel tumor subtype-specific biology","volume":"28","author":"Arora","year":"2026","journal-title":"Neuro Oncol."},{"issue":"1","key":"10.1016\/j.canlet.2026.218887_bib69","doi-asserted-by":"crossref","first-page":"4228","DOI":"10.1038\/s41598-023-31180-z","article-title":"Visualizing genomic characteristics across an RNA-seq based reference landscape of normal and neoplastic brain","volume":"13","author":"Arora","year":"2023","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.canlet.2026.218887_bib70","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/neuonc\/now247","article-title":"GlioVis data portal for visualization and analysis of brain tumor expression datasets","volume":"19","author":"Bowman","year":"2017","journal-title":"Neuro Oncol."},{"issue":"26","key":"10.1016\/j.canlet.2026.218887_bib71","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1056\/NEJMoa1402121","article-title":"Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas","volume":"372","author":"Cancer Genome Atlas Research","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2026.218887_bib72","doi-asserted-by":"crossref","DOI":"10.1038\/sdata.2017.24","article-title":"Comprehensive RNA-Seq transcriptomic profiling in the malignant progression of gliomas","volume":"4","author":"Zhao","year":"2017","journal-title":"Sci. Data"},{"issue":"43","key":"10.1016\/j.canlet.2026.218887_bib73","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.canlet.2026.218887_bib74","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1083\/jcb.201709121","article-title":"SIRF: quantitative in situ analysis of protein interactions at DNA replication forks","volume":"217","author":"Roy","year":"2018","journal-title":"JCB (J. Cell Biol.)"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526006518?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526006518?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T06:23:11Z","timestamp":1792822991000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383526006518"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":74,"alternative-id":["S0304383526006518"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218887","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genome-wide CRISPR screen identifies PKMYT1 inhibition as a synthetic lethal vulnerability in IDH1-mutant glioma","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218887","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"218887"}}